Stockscreener 앱 받기
1.9843
4.05%
0.0643
전일 마감가:
$1.92
열려 있는:
$2
하루 거래량:
1.28M
Relative Volume:
0.78
시가총액:
$453.13M
수익:
$8.95M
순이익/손실:
$-21.49M
주가수익비율:
-16.54
EPS:
-0.12
순현금흐름:
$-29.24M
1주 성능:
+14.15%
1개월 성능:
+18.21%
6개월 성능:
+307.11%
1년 성능:
+144.88%
1일 변동 폭
$1.96
$2.07
1주일 범위
$1.66
$2.07
52주 변동 폭
$0.3651
$2.07
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
명칭
Lineage Cell Therapeutics Inc
전화
510-871-4188
주소
2173 Salk Avenue, Suite 200, Carlsbad, CA
LCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.9843 | 438.44M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-20 | 개시 | Craig Hallum | Buy |
| 2022-11-02 | 개시 | Robert W. Baird | Outperform |
| 2022-06-14 | 개시 | B. Riley Securities | Buy |
| 2021-08-19 | 개시 | Noble Capital Markets | Outperform |
| 2021-03-31 | 개시 | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc 주식(LCTX)의 최신 뉴스
How to build a custom watchlist for Lineage Cell Therapeutics Inc.2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
How hedge fund analytics apply to Lineage Cell Therapeutics Inc. stock2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
How institutional buying supports Lineage Cell Therapeutics Inc. stockPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com
Is Lineage Cell Therapeutics Inc. stock undervalued historicallyMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Will Lineage Cell Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Recap & Weekly Market Pulse Alerts - newser.com
Lineage Cell Therapeutics (LCTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metrics2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
How Lineage Cell Therapeutics Inc. stock performs during market turbulence2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com
Tools to assess Lineage Cell Therapeutics Inc.’s risk profileEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Lineage Cell Therapeutics Hits New 52-Week High of $1.87 - Markets Mojo
How Lineage Cell Therapeutics Inc. stock moves on employment data2025 Momentum Check & Smart Money Movement Tracker - newser.com
Published on: 2025-11-02 02:45:07 - newser.com
Can Lineage Cell Therapeutics Inc. rally from current levelsJuly 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
How Lineage Cell Therapeutics Inc. stock reacts to Fed tightening - newser.com
Is Lineage Cell Therapeutics Inc. stock a top pick in earnings season2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock a momentum leaderQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Will Lineage Cell Therapeutics Inc. stock outperform international peersBear Alert & Growth Focused Investment Plans - newser.com
Regression analysis insights on Lineage Cell Therapeutics Inc. performanceWeekly Market Report & Daily Chart Pattern Signals - newser.com
Why hedge funds are buying Lineage Cell Therapeutics Inc. stockQuarterly Trade Report & Smart Swing Trading Techniques - newser.com
Published on: 2025-11-02 04:56:29 - newser.com
Published on: 2025-11-01 02:10:50 - newser.com
Tools to monitor Lineage Cell Therapeutics Inc. recovery probabilityIPO Watch & Risk Controlled Swing Alerts - newser.com
Lineage Cell Therapeutics to release Q3 2025 results, hosts business update call - Traders Union
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025 - Business Wire
Published on: 2025-10-30 05:00:08 - newser.com
Published on: 2025-10-29 06:15:34 - newser.com
Published on: 2025-10-29 06:04:11 - newser.com
Published on: 2025-10-29 04:52:09 - newser.com
Lineage Cell Therapeutics Inc (LCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):